Michael Rauh

Dr. Michael Rauh

Assistant Professor & Attending Hematopathologist, Queen's University, Kingston

Biography

Diagnosis of myeloid cancers requires invasive bone marrow sampling and is reliant on subjective microscopy, especially for MDS. My research aims to develop novel, blood-based, somatic mutation and digital gene expression assays to improve myeloid cancer diagnosis, risk and treatment stratification. The sensitivity of these assays enable us to detect pre-cancerous, clonal hematopoiesis (CHIP) and we aim to elucidate early clone-immune environment interactions to inform novel therapeutic directions.

Funded Projects

Extracellular vesicles in aging and clonal hematopoiesis »

The relationship between immunotherapy and clonal hematopoiesis of indeterminant potential (CHIP) in patients with advanced melanoma »

Path2MyDx: Personalized Molecular Pathology for Myeloid Cancer Diagnosis »



Research Specialties

Research Interests

  • Hematological
  • Molecular Pathology

Contact for Collaboration

Queen's University
99 University Avenue
Kingston, ON, K7L 3N6
Pathologists and Researchers who are interested in being part of the OMPRN: